OVERSEAS REGULATORY ANNOUNCEMENT

Hong Kong Exchanges and Clearing Limited and the Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement makes no representation as to its accuracy or completeness and expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.山东威高集团医用高分子制品股份有限公司 Shandong Weigao Group Medical Polymer Company Limited * (a joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 1066) OVERSEAS REGULATORY ANNOUNCEMENT This announcement is made pursuant to the disclosure requirements under Rule 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited. According to the relevant regulations of the People’s Republic of China Shandong Weigao Orthopaedic Device Company Limited published the announcement on the website of Shanghai Stock Exchange (http://www.sse.com.cn/home/search/?webswd=688161). An announcement has just been published by the issuer in the Chinese section of this website.By Order of the Board Shandong Weigao Group Medical Polymer Company Limited Long Jing Chairman 24 June 2024 Weihai Shandong the PRC As at the date of this announcement the Board comprises: Mr. Long Jing (Executive Director) Mr. Cong Rinan (Executive Director) Mr. Lu Junqiang (Executive Director) Mr. Wang Daoming (Executive Director) Mr. Tang Zhengpeng (Non-executive Director) Mr. Chen Lin (Non-executive Director) Ms. Yan Xia (Non-executive Director) Mr. Li Guohui (Independent Non-executive Director) Mrs. Meng Hong (Independent Non-executive Director) Mr. Li Qiang (Independent Non-executive Director) Mr. Sun Heng (Independent Non-executive Director) *　For identification purpose only